Moderna (MRNA) PT Raised to $179 at Oppenheimer, 'mResvia is competitive as an RSV vaccine'
Go back to Moderna (MRNA) PT Raised to $179 at Oppenheimer, 'mResvia is competitive as an RSV vaccine'| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 63.96 +2.16 (3.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.80 | 52 Week High | $0.52 | |||
| Open | $63.96 | 52 Week Low | $0.08 | |||
| Day High | $65.42 | P/E | N/A | |||
| Day Low | $60.73 | EPS | $-3.80 | |||
| Volume | 24,078,869 | |||||
